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Background: Cross-infection of Pseudomonas aeruginosa has been reported to occur at holiday camps for children with Cystic Fibrosis
(CF) with varying frequency. The study aimed to establish the degree of transmission resulting in subsequent infection of P. aeruginosa
among CF children (n=80) attending holiday camps in The Netherlands.
Methods: The study was performed in the summer of 2001 in four camps organised simultaneously at different locations. Sputum was
collected on day 1 of the holiday, and three and six months later. Different morphotypes of P. aeruginosa from sputum were genotyped by
AFLP™ analysis. Criteria were defined for the degree of evidence of transmission.
Results: There were 18 cases possible, 2 cases of probable transmission and 1 case of highly probable transmission. Two predominant types
of P. aeruginosa were found (types 18 and 23). Type 18 was already prevalent on day 1 mostly in younger children and was involved in
eleven cases of transmission; type 23 was involved in six cases of transmission among older children.
Conclusions: There was a considerable risk of transmission of P. aeruginosa during holiday camps for CF children in The Netherlands. Two
genotypes of P. aeruginosa appeared to be easily transmissible, one of which seemed common in the Dutch CF population.
© 2007 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic Fibrosis; Pseudomonas aeruginosa; Camp; Transmission; Epidemic1. Introduction
Pseudomonas aeruginosa is a notorious pathogen in Cystic
Fibrosis (CF) patients. The acquisition of P. aeruginosa and
subsequent development of chronic infection leads to
increased morbidity and earlier mortality in CF patients as
compared to those who have remained P. aeruginosa free [1].
Therefore, it is important to protect patients against infection
with P. aeruginosa. Bacteria belonging to Burkholderia
cepacia complex, organisms with a transmission mode similar
to that of P. aeruginosa [2,3], have been shown to be⁎ Corresponding author. Tel.: +31 70 3592271; fax: +31 70 3592264.
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doi:10.1016/j.jcf.2007.04.002transmitted among CF children in holiday camps [4]. As a
consequence, children with strains belonging to the B. cepacia
complex can no longer join holiday camps or other social
activities with CF patients. It has become a policy in many
countries to stop organising holiday camps of CF patients in
order to prevent P. aeruginosa acquisition. For the latter
organism, however, it has not been shown unambiguously that
there is a high risk of acquisition in these camps. One
retrospective analysis of a study performed in a summer camp
in 1976 in The Netherlands showed a rate of sputum
conversion for P. aeruginosa of 7.7% among previously
P. aeruginosa negative children, but only 1.9% remained
colonised after two months of follow-up [5]. The authors,
therefore, saw no reason to advise CF children to refrain fromed by Elsevier B.V. All rights reserved.
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rospective investigation in Denmark [6], transmission was
found in all children (n=5) who did not carry P. aeruginosa
prior to attending the holiday camp. The advice was to seg-
regate the CF children into groups according to their
P. aeruginosa status during social activities such as these
camps. From a study byHunfeld et al. [7] it was concluded that
the risk of cross-colonisation during a summer camp probably
is not much higher than the reported incidence of acquisition of
the pathogen from the environment. The risk of P. aeruginosa
spreading in camps was consideredminor in comparison to the
medical, social and psychological benefits of such camps for
CF patients. Another study to determine the transmission of
P. aeruginosa among CF patients during three consecutive
winter camps in a health camp could not demonstrate cross-
infection of P. aeruginosa [8].
The conflicting outcomes of these studies [5–8] on the
risk of transmission of P. aeruginosa during holiday camps
challenged us to gather more evidence before recommenda-
tions on the continuation of CF camps in The Netherlands
could be given. The aim of the present prospective study was
to establish the degree of transmission resulting in subse-
quent infection of P. aeruginosa among children with CF
attending holiday camps in The Netherlands.
2. Methods
2.1. Patients and camps
The study was performed in the summer of 2001 in four
summer holiday camps organised simultaneously at different
locations in The Netherlands. The period of stay in each
camp was eight days. The camps ranged according to the age
category of the participants: camp 1 had 16 participants age
6–11 years, camp 2 had 19 participants age 11–13, camp 3
had 24 participants age 13–15 and camp 4 had 21 par-
ticipants age 15–19 years.
All children had a ‘non-cepacia’ declaration from their
medical attendant, which implies that bacteria of the
B. cepacia complex had never been cultured from the
child's sputum and that within the last six months at least one
sputum culture was done.
All participants received written information about the
purpose and the consequences of the investigation. It was
agreed that patients nor their medical attendants would be
informed about the individual culture results, unless a strain
belonging to the B. cepacia complex or a methicillin
resistant Staphylococcus aureus (MRSA) would be isolated.
Consent was obtained from the participants. The study was
approved by the ethics committee of HagaZiekenhuis
(former Ziekenhuis Leyenburg).
2.2. Bacteriology
Sputum was collected on day 1 of the holiday (T1), after
three months (T2), and after six months (T3). Thesesampling points were chosen as practical for establishing
transmission of P. aeruginosa resulting in chronic infection.
Patients were asked to produce sputum spontaneously by
coughing, while a pharyngeal swab was taken if no sputum
could be produced. In 8 times (7 children) no culture could
be obtained due to absence at the sampling times. No envi-
ronmental sampling was done in and around the camps. All
sputum samples and swabs were processed for isolation and
identification of P. aeruginosa in one laboratory. Species
identification of P. aeruginosa was performed on the basis of
a positive oxidase test, pigment production, hydrolysis of
acetamide, resistance to the combination of C-390 and
phenantroline. In case of doubt, additional identification with
the API 20-NE system (bioMérieux, Marcy l'Etoile, France)
was performed. Different morphotypes of P. aeruginosa
from the sputum sample were isolated and stored in glycerol
broth at minus 80 °C for typing at a later date. All samples
were also investigated for the presence of B. cepacia com-
plex and MRSA as their presence would result in isolation
measures.
2.3. AFLP analysis
Genotypic relatedness of strains was assessed by
AFLP™, a high resolution genomic fingerprinting method
[9]. Briefly, purified DNA was digested using EcoRI and
MseI, while ligation of EcoRI and MseI adapters to the
restriction fragments was performed simultaneously. PCR
was done with a Cy5-labelled EcoRI primer and a MseI+C
primer (C, selective nucleotide). The ALF express system
(Amersham Biosciences, Roosendaal, The Netherlands) was
used for fragment separation. Isolates were grouped for their
similarity of fragments of 50–500 bp by cluster analysis with
the BioNumerics software release 2.5 (Applied Maths, Sint-
Martens-Latem, Belgium). Pearson product moment coeffi-
cient (r) was used as a measure of similarity, and the
unweighted pair group average linkage method (UPGMA)
for grouping. The optimisation setting was 0.5%, and the
final area for cluster analysis was 7.0–95.2% of the profile.
2.4. Pulsed field gel electrophoresis (PFGE)
Macrorestriction analysis by PFGE was performed as
described previously [10] with the following modifications
[11]: a Gram-positive bacteria lysis step (using lysis buffer
containing 500 μg lysozyme ml−1) was included prior to the
addition of Gram-negative lysis buffer. DNA was digested
with 30 U SpeI (Helena BioSciences Europe, Tyne & Wear,
UK) in the accompanying Y+/Tango buffer with BSA.
Fragments were separated with the CHEF DRII apparatus
(Bio-Rad, Hemel Hempstead, UK) in a 1.2% agarose gel.
Initial and final switching times were 1 and 50 s respectively.
Running conditions were: temperature 12 °C, angle of 120°,
and run time 30 h at 6 V/cm. Following staining with
ethidium bromide, gels were photographed and profiles were
analysed visually and by cluster analysis with BioNumerics
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measure and UPGMA for grouping.
2.5. Definitions of transmission
Transmission was defined as the finding of a P. aeruginosa
AFLP type that was not present in the sputum of the patient at
entry of the camp (T1), but was present at a later time (T2 and/
or T3), and that this specific type of P. aeruginosawas present
in another patient at T1 in this camp.
If at T1 from a patient no P. aeruginosa was cultured, the
history of P. aeruginosa infection of this patient was sought.
Culture results of sputum or throat in the two years preceding
the camp were inquired at the medical centre the patient had
visited. For this purpose a minimum of three cultures was
considered acceptable.
Criteria were defined for the degree of evidence of trans-
mission. Transmission was considered “highly probable”, if
a patient had a negative history of P. aeruginosa prior to the
camp period, and if this patient was (P. aeruginosa) negative
at T1, but (P. aeruginosa) positive at T2, and positive or
negative at T3 for a given strain type circulating in the camp.
Transmission was considered “probable” in case of a
negative history of P. aeruginosa, a negative culture at T1
and T2 but positive at T3 for a type circulating in the camp.
Transmission was assumed “possible” if a patient had a
positive history of P. aeruginosa (of an unknown strain
type), was negative at T1 but positive at T2 and/or T3 with a
type of P. aeruginosa found among the camp attendants. All
other combinations were considered as “no transmission”.
3. Results
3.1. Patients and camps
The study comprised of 80 children with CF in the age
range of 6–19 years, including a few sets of siblings,
attending one of four summer camps. These children were
treated in 24 different hospitals in The Netherlands. Seventy-
one out of the 80 children were positive for P. aeruginosa at
one or more of the sampling moments (T1–T3). Twenty-
three patients were negative at T1, but further enquiries
showed that 17 of them had a positive sputum or throat
culture in the two years prior to the camp. Of the 215 sputum
cultures 162 were positive for P. aeruginosa (75%). In total
17 throat cultures were taken from which 13 were positive
for P. aeruginosa (76%). The general sensitivity of culture to
establish infection with P. aeruginosa in these groups, taking
their history of prior P. aeruginosa infection into account,
was 77, 78 and 78% respectively for T1, T2 and T3.
From each of the 71 children, the isolates were selected
per sample in the clinical laboratory on the basis of their
unique colony morphology and considered possibly to rep-
resent different strains. Thus, 255 isolates including different
morphotypes from individual patients were left for genotyp-
ing by AFLP analysis. Concordance of AFLP results withPFGE analysis was sought for a subset of isolates. No
patients harboured strains of B. cepacia complex, and one
patient had a positive sputum culture for MRSA at T2.
3.2. Genotyping: validation and results
AFLP analysis was first validated for its ability to type
P. aeruginosa strains by assessing the marker stability –
i.e., the stability of AFLP profiles of strains – the dis-
criminatory capacity and the reproducibility of the method
[12]. Marker stability was estimated by comparing profiles
of sequential isolates from 14 patients each. The discrim-
inatory capacity of the method was tested on a set of 18
epidemiologically unrelated isolates. Cluster analysis of the
resulting profiles depicted in a dendrogram showed that, at
a cluster cutoff level of 88%, multiple isolates of each
patient clustered together, while unrelated strains were
ungrouped (data not shown). The reproducibility of the
method was assessed by comparing independently pro-
cessed samples of one control strain (ATCC 27853) the
profiles of which grouped at 84.54±3.41%. Based on the
noted marker stability and the reproducibility of the
method, the 85% level was considered the level to delineate
strains. First, this level was used to exclude multiple
isolates of the same strain in one patient sample, resulting
in 197 isolates from 71 patients. Next, at the same cluster
cutoff level AFLP analysis of these 197 isolates was done.
Thus, a total of 24 well separated clusters (AFLP types),
designated 1–24 were distinguished (Fig. 1). Predominant
AFLP types were type 18 in 47 patients, type 23 in seven
patients, type 13 in six patients and type 1 in five patients.
To verify the validity of the AFLP profiling, a subset of ten
isolates, including seven of AFLP type 18 and three ad-
ditional isolates of AFLP types 13, 15 and 19 were an-
alysed by PFGE. The analysis also included two epidemic
CF strains circulating in Liverpool and Manchester (United
Kingdom). The grouping of the PFGE profiles of the
organisms as depicted in a dendogram, the actual PFGE
profiles, the AFLP designation and origin are shown in
Fig. 2. The figure shows clearly the consistency of PFGE
banding profiles for the isolates allocated to AFLP type 18;
these clustered at 85% and had no more than three band
differences. The other profiles including those from the
epidemic UK strains were clearly distinct. Further analysis
revealed that the AFLP types 13, 15, 18 and 19 were also
distinct from two epidemic strains clone C from Hanover
(G) [13], the epidemic strain Mdl from Birmingham (UK)
[Scott] and from isolates from CF patients in the Czech
Republic (data not shown).
3.3. Distribution of different strains among patients and
camps
In camp 1, with the youngest children, only five different
types (types 4, 8, 16, 18, 22) were distinguished at T1, of
which type 18 was the most predominant. In one child in this
Fig. 1. Dendrogram, clustering AFLP types ofP. aeruginosa isolates found in this study with the number of isolates and the number of patients involved for this type.
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Fig. 2. Dendrogram of cluster analysis of PFGE profiles of a subset of P. aeruginosa isolates from different CF patients. The corresponding AFLP profiles and
origin of the strains are on the right. Two strains from the United Kingdom are epidemic strains from Liverpool (LUH7922) and Manchester (LUH7924). Un,
unique profile.
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and T3. In camp 2, five types (types 10, 14, 18, 19, 24) were
found at T1, while one additional type (type 8) was found in
one patient at T2. In camp 3, nine types (types 1, 2, 3, 8, 13,
15, 16, 18, 21) were found at T1, and two additional types
(types 10, 20 in two children) at T2/T3. In camp 4, eight
types (types 1, 5, 6, 12, 13, 17, 18, 23) were found at T1,
while at T2/T3 in these patients two additional types (types
7, 9) were encountered.
The occurrence of type 18 at T1, in particular in camps 1–
3, was strikingly high with a distribution in camps 1–4 in 8,
9, 16 and 3 children respectively, while other types were
relatively rare.
3.4. Transmission
There were 18 cases of possible, 2 cases of probable
transmission and there was 1 case of highly probable trans-
mission (Table 1). All cases of transmission in camps 1 and 2
were confined to type 18; types 3 and 21 played a role inTable 1
Possible, probable and highly probable cases of transmission of P.
aeruginosa
Camp Number
of
children
Transmission
possible
Transmission
probable
Transmission
highly
probable
Type a
(N) b
1 16 2 1 0 18 (3)
2 19 6 0 1 18 (7)
3 24 2 0 0 3 (1), 21
(1)
4 21 8 1 0 13 (2), 23
(6 ) , 1 8
(1)
a Types delineated by AFLP.
b Number of transmissions.camp 3. In camp 4 with the oldest CF patients, type 18
played a minor role as compared to types 13 and 23. At T1
one child in camp 4 was the only carrier of a P. aeruginosa of
type 23; at T2 however six other children were also infected
with this type (categorised as possible transmissions). In
these camps 10 sets of siblings were included (n=21). Seven
of them had identical types of P. aeruginosa in their sputum
during the whole period. Three sets of siblings had different
types during this period of six months. We did not see
transmission between these three sets of siblings.
4. Discussion
In 21 of the 80 children, who attended one of the four
separate camps, infection of a new P. aeruginosa type, that
was present at the beginning of these summer camps, was
established. As one can never be sure of the exact moment
of transmission, the patterns of culture/typing results over
time were categorised into evidence of possible, probable
and highly probable transmission. No typing data of the
P. aeruginosa strains cultured in the period before these
camps took place were available. As a consequence of this
lack of information the transmissions in this particular
group were graded not higher than “possible”, as it could not
be excluded, that the children were already carrying this
strain type before joining the camp.
Another weakness is the sensitivity of culture (78%) to
detect infection with P. aeruginosa. This means that some
infected children were missed at T1 and when their cultures
were positive at T2 or T3 for a camp-related type, this was
categorised as a transmission. But using the grading system
we categorised this as a “possible” transmission. This sen-
sitivity is confined to this group of clinically stable children
aged 6 to 19 years.
On the other hand, only seven of the 80 children had a
unique P. aeruginosa type at T2 or T3, that was not present
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transmissions of P. aeruginosa have occurred in the period
that the camps were attended.
Three of the six children, with no prior history of
P. aeruginosa infection, had a camp-related P. aeruginosa
type three or sixmonths after the camp.This percentage of 50%
may be less than the findings of Ojeniyi [6], but is definitely
more than the incidence of permanent colonisation and in-
fection ofP. aeruginosa of 1.9% after 2 months of follow-up as
seen in a previous study in The Netherlands [5]. The trans-
missions in this group were graded as probable or highly
probable due to their negative history of P. aeruginosa in-
fection up to two years preceding this camp.
An unexpected finding was the dominant presence of one
type of P. aeruginosa (type 18), particular in the younger
children. The high prevalence of type 18 at the time of the
camp within the groups 1, 2 and 3 may have contributed that
most transmissions have occurred with this specific type.
Frequent previous participations in these holiday camps could
not be related to the high prevalence of type 18. The 36
children, who had a type 18 at T1, had participated in these
camps a 192 times cumulatively (mean 5,3 times). The 33
children, who were not infected with type 18 at T1 and
thereafter, had participated in these camps a 184 times cumu-
latively (mean 5,6 times).
Linking types to the CF centres attended by the infected
children showed that nearly all centres (20/24) had one or
more children in their care infected with type 18, em-
phasizing its wide occurrence in the Netherlands CF patient
population. Remarkable is that in camp 4, which was the
camp with the oldest children, only 3 of the 21 children were
infected with type 18 at T1. This suggests that type 18 is not
universally present within the total CF population or the
environment, and therefore supports the argument that the
observed transmissions have taken place in the camps.
In camp 4 possible transmission of P. aeruginosa type 23
appeared to have occurred from one single child to six
others. Seemingly types 18 and 23 had the capacity to spread
among the CF children and, consequently, might be called
epidemic strains. Future studies are required to assess the
prevalence of these strains in the different centres and
whether this ability to spread epidemically is also linked with
an increase in virulence, as was described for an epidemic
strain from Liverpool, UK [14].
The prevalence of P. aeruginosa in our study population
was surprisingly high at the start: only six children attending
these holiday camps had no history of infection with P.
aeruginosa. An explanation could be that parents keep their
non-infected children away from joining other CF children in
summer camps; or children infected with P. aeruginosa are
more handicapped by their disease so that they prefer a
summer camp with specific medical support.
The living and social conditions in camps for children or
adults with CF vary and may partly explain the differences of
outcome of the other studies [5–8] on transmission of
P. aeruginosa. The children of these four Dutch camps werefrom the same age group, with many adolescents, most being
already familiar with each other and a holiday camp is very
much considered as a social paradise for these individuals: no
segregation policy was in place.
The organisers were knowledgeable that in some other
countries these holiday camps had been ended because of the
risk of transmission of P. aeruginosa. One prior study in
summer camps in The Netherlands [5] did not demonstrate a
risk of transmission of P. aeruginosa and in that study no
predominant strains were detected. The organisers and their
medical advisory board were therefore reluctant to follow the
guidelines of other countries to end these popular camps. The
results of this study have made the Dutch CF community
aware, that epidemic strains may have emerged and that
participating in these summer camps, without some form of
segregation, does carry a risk of acquiring P. aeruginosa.
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